Home >> Industry News >> Sysmex adds FDA-cleared CellaVision DC-1 to portfolio

Sysmex adds FDA-cleared CellaVision DC-1 to portfolio

image_pdfCreate PDF

“The solution for both standalone and networked installation, the CellaVision DC-1 closes the technology gap between larger and smaller labs,” Andy Hay, chief operating officer of Sysmex America, said in a press statement. “The CellaVision DC-1 provides labs high-quality digital imaging for improved efficiency, quality, connectivity, and staff proficiency.”

The analyzer is available now in the United States and Canada.

CAP TODAY
X